No matches

54 search results for: diagnosis

Impact of Delayed EoE <b>Diagnosis</b> on Disease Progression and QoL

Gastroenterology

Impact of Delayed EoE Diagnosis on Disease Progression and QoL

2 min

expert video

Join Prof. Arjan Bredenoord as he discusses the importance of early diagnosis of EoE.

Gastroenterology

ADVENT On Air | Be on the Lookout for EoE: The Importance of Early Diagnosis

18 min

Podcast

Join Dr. Aceves and Ms. Ugras as they share their insights on how to identify potential patients with EoE and the importance of early diagnosis.

Gastroenterology

Eosinophilic Esophagitis (EoE) Pediatric Interactive Patient Case

8 min

interactivity

Experience a pediatric patient's journey from infancy to adolescence with guideline-based learnings on EoE diagnosis, treatment, and long-term care.

FeNO Is a Noninvasive Biomarker That Can Support <b>Diagnosis</b> and Management for Asthma Patients

Pulmonology

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

3 min

Infographic

Learn how FeNO, a noninvasive biomarker for type 2 inflammation, can be used to optimize care for asthma patients.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: GuatemalaChange country/region